Advaxis

ADXS

3.14

+0.14

+4.7%

After Hours:

3.14

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 3.01
Prev. Close: 3.00
Low/Hi: 3.00 - 3.17
52-Week: 2.83 - 10.06
Volumes
Equity: 508,323
90-Day Avg: 734,178
Option: 57
90-Day Avg: 210
Volatility
Todays Stock Vol: 63.4
20-Day (HV): 76.0
52-Week (HV): 63.0
30-Day IV: 66.3 -0.4
IV Pct Rank: 51% Moderate
Fundamental
Div. Yield:
Earnings: 8-Jan (Est.)
P/E Ratio:
Market Cap: 123.2 M
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ADXS Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Jan-2017 31-Oct-2016 31-Jul-2016 30-Apr-2016
Net Income -17,081 -21,703 -16,486 -15,522
Change in Working Capital -2,509 39,425 -3,472 -1,375
Depreciation Amortization Depletion and Accretion 276 223 187 192
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 5,217 4,125 5,388 4,840
Total Cash from Operating Activities -14,097 22,071 -14,383 -11,867
Capital Expenditures -1,208 -1,843 -1,411 -580
Other Investing Cash Flow -40,003 9,605 621 -1,603
Total Cash from Investing Activities -41,211 7,763 -790 -2,183
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 0 53,184 9 320
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 124 -9 -19 -16
Total Cash from Financing Activities 124 53,175 -10 303
Exchange Rate Effects 0 0 0 0
Net Change in Cash -55,184 83,009 -15,182 -13,746
Period Ending 31-Oct-2016 31-Oct-2015 31-Oct-2014
Net Income -73,556 -47,031 -16,525
Change in Working Capital 39,854 1,028 -4,548
Depreciation Amortization Depletion and Accretion 789 326 203
Deferred Taxes 0 0 0
Other Non-Cash Activities 23,843 21,542 3,848
Total Cash from Operating Activities -9,071 -24,136 -17,022
Capital Expenditures -4,449 -1,795 -440
Other Investing Cash Flow 6,005 -45,655 0
Total Cash from Investing Activities 1,556 -47,450 -440
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 53,765 121,916 14,581
Purchase and Retirement of Debt 0 0 -65
Other Financing Cash Flow -61 -1,376 0
Total Cash from Financing Activities 53,704 120,540 14,516
Exchange Rate Effects 0 0 0
Net Change in Cash 46,189 48,955 -2,945